{"data":{"id":"us/21-cfr-170.260","jurisdiction":"us","citation":"21 CFR 170.260","heading":"Steps you may take before FDA responds to your GRAS notice.","body":"(a) You may submit a timely amendment to your filed GRAS notice, to update your GRAS notice or in response to a question from us, before we respond to your notice by letter in accordance with § 170.265(b)(1) or cease to evaluate your notice in accordance with § 170.265(b)(3).\n(b) At any time before we respond to your GRAS notice in accordance with § 170.265(b)(1), you may request in writing that we cease to evaluate your GRAS notice. Your request does not preclude you from submitting a future GRAS notice in accordance with this subpart with respect to the notified substance.","path":["Title 21—Food and Drugs","CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES","SUBCHAPTER B—FOOD FOR HUMAN CONSUMPTION","PART 170—FOOD ADDITIVES","Subpart E—Generally Recognized as Safe (GRAS) Notice"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-21.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:24:47Z","sha256":"acfefe39af97dd26c37f09c5d6f06d436164a52544c99c55fe4722822181bf0c","source_id":"us-cfr","stale":true,"prev":"us/21-cfr-170.255","next":"us/21-cfr-170.265"},"notice":"GroundRules: Original legal text. Not legal advice."}